Sessions will include DTM™ SCS endurance therapy 3-month outcomes for patients with chronic back and leg pain
Scientific Presentations
The following poster and oral scientific data presentations reflect evidence from Medtronic-sponsored research and collaborations with external partners. Poster presentations will be available to all attendees with an option to query the presenters throughout the conference.
DTM™ SCS and DTM™ SCS Endurance Therapy
- "A Prospective Multi-Center Study of a Differential Target Multiplexed™ Stimulation Derivative in Therapy-Naïve Patients: Primary Endpoint and 3-Month Outcomes" – oral presentation by Dr.
Kas Amirdelfan , M.D. onFriday, January 14 . - "Modeling Energy Demands of a Reduced-Energy Derivative of Differential Target Multiplexed™ Stimulation on a Rechargeable and Recharge-free Systems" – poster presentation by Dr.
David Provenzano , M.D. onFriday, January 14 . - "A
RCT Comparing Traditional and DTM SCS for Chronic Back andLega Pain : Profound Pain Relief, Functional and QoL Benefits" – oral presentation by Dr.Harold Cordner , M.D. onSaturday, January 15 . - "A Randomized Controlled Trial of DTM™ SCS Compared to
Traditional SCS for Intractable Chronic Low Back and Leg Pain: Pain Relief, Therapy Satisfaction and Sensory Experience" – oral presentation by Dr.Michael Fishman , M.D. onSaturday, January 15 . - "Successful Reduction of
Chronic Upper Limb and Neck Pain Using DTM SCS " – e-poster presentation by Dr.Ricardo Vallejo , M.D.
DTM™ SCS Pre-Clinical Presentations
- "Transcriptomics of Differential Target Multiplexed SCS Using Reduced Energy in a Model of Neuropathic Pain" – oral presentation by
David Cedeno , Ph.D. onSaturday, January 15 . - "Cell-Specific Transcriptomics of
DTM SCS in a Model of Neuropathic Pain: Effect of Stimulation Intensity" oral presentation by Dr.Ricardo Vallejo , M.D. onSaturday, January 15 . - "SCS Alters Spinal Cord Gene Expression" – oral presentation by
David Cedeno , Ph.D. onSaturday, January 15 . - "Differential Target Multiplexed SCS Modulated MAPK Pathway in an Animal Model of Neuropathic Pain" – oral presentation by
Dana Tilley , Ph.D onSaturday, January 15 . - "Differential Target Multiplexed SCS Modulates mTOR Signaling in an Animal Model of Neuropathic Pain" – poster presentation by Dr.
Francesco Vetri , M.D. onFriday, January 14 .
Targeted Drug Delivery
- "Embrace TDD Primary Objective Results: Clinical Success Rate with Low Dose Intrathecal Morphine Monotherapy (LDITM)" – poster presentation by Dr.
Chris Beuer , M.D. onFriday, January 14 . - "Low Dose Intrathecal Morphine Monotherapy (LDITM) for Chronic Nonmalignant Pain (NMP): Trialing Methods and Safety" – poster presentation by Dr.
Michael Danko , M.D. onFriday, January 14 . - "Systemic Opioid Weaning and Low Dose Intrathecal Morphine Monotherapy (LDITM) for Chronic Nonmalignant Pain (NMP)" – poster presentation by Dr.
Michael Danko , M.D. onFriday, January 14 . - "Patient Controlled Intrathecal Analgesia with Intrathecal Morphine for Chronic Nonmalignant Pain (NMP)" – poster presentation by Dr.
Michael Saulino , M.D. onFriday, January 14 . - "Updated Longitudinal Data from the TDD Product Surveillance Registry: Effect of Pump Durable Design Changes" – poster presentation by Dr.
Alaa Abd-Elsayed , M.D. onFriday, January 14 . - "Longitudinal Data from the Targeted Drug Delivery (TDD) Product Surveillance Registry (PSR): Trialing Characterization – e-poster presentation by Dr. Sam Eldabe, M.D.
- "PSR TDD Latin America Experience" – poster presentation by Dr.
Fabian Piedimonte , M.D.
Evoked Compound Action Potentials (ECAPs)
- "Optimal Methods for Spinal Evoked Compound Action Potential Estimation" – oral presentation by Dr.
Krishnan Chakravarthy , M.D., Ph.D. onFriday, January 14 . - "The Spinal Evoked Compound Action Potential as a Predictor for Perception" – oral presentation by
Julie Pilitsis , M.D., Ph.D. onFriday, January 14 . - "The Effect of Electrode Selection on Optimal Spinal Evoked Compound Action Potential Sensing" – oral presentation by Dr.
Michael Fishman , M.D. onFriday, January 14 . - "Clinical Feasibility of in Home, Closed-Loop Spinal Cord Stimulation with Differential Target Multiplexed Therapy" – oral presentation by Dr.
Tristan Weaver , M.D. onFriday, January 14 . - "A Closed-Form Expression for the Spinal Evoked Compound Action Potential Growth Curve" – poster presentation by
Leo Litvak , Ph.D.
Deep Brain Stimulation (DBS)
- "Around-the-clock Monitoring of STN Beta-band LFPs Reveal Diurnal Variation in STN-DBS Parkinsonian Patients" –poster presentation by Dr.
Genko Oyama , M.D. onFriday, January 14 .
Medtronic Sponsored Event
The following lunch symposium is open to attending healthcare professionals and will feature detailed clinical evidence and discussions with Medtronic and independent speakers.
- "Personalizing
Patient Care : How innovative therapies and technology are transforming SCS" presented by Dr.Erika Petersen , Dr.Krishnan Chakravarthy , Dr.Tammy Dann , andJeff Kramer onJanuary 14 at12:00 p.m. : - Learn how DTM™ SCS therapy is uniquely inspired by science and proven in an RCT to provide superior pain relief on Intellis™
- Hear how personalize care is advancing with the unveiling of the latest research results for DTM™ SCS endurance therapy
- Discover how SCS will be transformed by future technologies
About Medtronic
Bold thinking. Bolder actions. We are Medtronic.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the
Contacts: | |
Jeff Trauring | |
Public Relations | Investor Relations |
+1-763-760-0001 | +1-763-505-4626 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/medtronic-announces-schedule-for-presentations-at-the-2022-north-american-neuromodulation-society-meeting-301459059.html
SOURCE
© Canada Newswire, source